Revolution Medicines Inc

-0.36 (-1.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.15B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.17 Million
Adjusted EPS-$0.84
See more estimates
10-Day MA$23.93
50-Day MA$21.29
200-Day MA$22.75
See more pivots

Revolution Medicines Inc Stock, NASDAQ:RVMD

700 Saginaw Drive, Redwood City, California 94063
United States of America
Phone: +1.650.481.6801
Number of Employees: 188


Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.